Ordaos Bio

Ordaōs Bio is a biotechnology company based in New York that specializes in AI-driven drug design. The company focuses on creating novel therapeutic mini-proteins through a combination of human expertise and machine learning. Ordaōs aims to address unmet medical needs efficiently by utilizing *de novo* protein design, reducing reliance on traditional scientific methods. The team consists of 11–50 employees and collaborates with pharmaceutical companies, biotechs, and academic institutions worldwide. One of Ordaōs's key offerings is the miniPRO™ proteins, which are designed to mimic antibody functionality while being significantly smaller and more stable. The company also features an AI-driven design engine that generates and evaluates protein sequences quickly, optimizing their properties for clinical viability. Ordaōs emphasizes rapid development, with programs progressing from design to functional testing in a matter of weeks. Their mission is to reduce patient suffering by delivering safer and more effective therapies through precision design.

Research New York, United States ~21 employees

Work at Ordaos Bio in HR or recruiting? Claim this page

Employees
21
0% in the 3 months to Sep 2026
Revenue / employee
$238K
Revenue ~$5M
Total funding
$10.6M
Last round Feb 2025
12-month attrition
15.3%
Tech: 20.8%
H1B sponsor
NA

Headcount trend

Ordaos Bio went from 29 employees in Oct 2024 to 21 in Sep 2026.

Funding rounds

Total funding$10.6M
Funding rounds5
Investors6
DateRoundMoney raisedNo.Investors
Feb 2025Funding$338K1
Aug 2024Funding$3.1M2
Dec 2023Convertible Note$332K2
Aug 2023Debt Financing$1.8M2
Aug 2022Seed$5M5

Org structure

Headcount by department

Other15
Engineering5
Operations1

Ordaos Bio FAQ

How many employees does Ordaos Bio have?

Ordaos Bio has about 21 employees, unchanged over the 3 months to Sep 2026.

What is Ordaos Bio's revenue per employee?

Ordaos Bio makes about $238K in revenue per employee, based on $5M annual revenue and 21 employees.

How much funding has Ordaos Bio raised?

Ordaos Bio has raised $10.57M in total funding.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.